Pharmaceutical News

RSS

Beta-blockers reduce mortality in patients with heart failure and moderate kidney dysfunction

Beta-blockers reduce mortality in patients with heart failure and moderate kidney dysfunction

Beta-blockers remain effective for preventing death in heart failure with reduced ejection fraction (HFrEF) and sinus rhythm, even in patients with moderate or moderately-severe kidney dysfunction, according to late breaking research presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology.

3 Sep 2019

Studies reveal how popular drug helps in heart failure

Studies reveal how popular drug helps in heart failure

Results were released today from the first two clinical studies designed specifically to examine the effects of the heart drug sacubitril/valsartan on the structure and function of the failing heart.

3 Sep 2019

Non-medical use of prescription amphetamines for ADHD linked to hospitalization, fatal outcomes

Non-medical use of prescription amphetamines for ADHD linked to hospitalization, fatal outcomes

New findings on the serious adverse outcomes associated with non-medical use (NMU) of prescription amphetamines for attention deficit hyperactivity disorder were recently published in the September 2019 issue of the Journal of Attention Disorders.

30 Aug 2019

Shopping at the Apotheke: Compare German pharmacies with your corner drugstore

Shopping at the Apotheke: Compare German pharmacies with your corner drugstore

If you're looking for bobby pins, cheap lipstick or a protein bar, well, sorry, Americans, the German pharmacy can't help you.

30 Aug 2019

Tanner Pharma Group delivers on “last mile” in global health

Tanner Pharma Group delivers on “last mile” in global health

The Max Foundation, an international health organization dedicated to serving cancer patients, and Tanner Pharma Group, a global pharma services company specializing in access to critical medication, are committed partners in bringing thousands of patients around the globe daily access to cancer treatment.

From Tanner Pharma Group 29 Aug 2019

Tanner Pharma Group signs a distribution agreement for partner therapeutics’ product

Tanner Pharma Group signs a distribution agreement for partner therapeutics’ product

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Partner Therapeutics, Inc., an integrated biopharmaceutical company.

From Tanner Pharma Group 29 Aug 2019

Tanner Pharma Group to attend CTS Europe, DCAT, PharmagoraPlus, PQMD, and GCSG US conferences

Tanner Pharma Group to attend CTS Europe, DCAT, PharmagoraPlus, PQMD, and GCSG US conferences

Key directors from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend several international healthcare conferences throughout the upcoming months of March and April.

From Tanner Pharma Group 29 Aug 2019

Tanner Pharma Group signs distribution agreement with Nephcentric LLC

Tanner Pharma Group signs distribution agreement with Nephcentric LLC

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Nephcentric LLC, a developer and marketer of evidence based therapeutic options for people with kidney disease and metabolic disorders.

From Tanner Pharma Group 29 Aug 2019

Tanner Pharma Group signs distribution agreement with MannKind Corporation

Tanner Pharma Group signs distribution agreement with MannKind Corporation

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with MannKind Corporation, a biopharmaceutical company focused on inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension.

From Tanner Pharma Group 29 Aug 2019

New type 2 diabetes drug associated with reduced risk of heart failure and death

New type 2 diabetes drug associated with reduced risk of heart failure and death

The new type of drugs for type 2 diabetes, the so-called SGLT2 inhibitors, are associated with a reduced risk of heart failure and death as well as of major cardiovascular events, a major Scandinavian registry study led from Karolinska Institutet reports in The BMJ.

29 Aug 2019

New 'ETAK Antimicrobial Wet Wipes' for elimination of viruses, bacteria on personal belongings

New 'ETAK Antimicrobial Wet Wipes' for elimination of viruses, bacteria on personal belongings

Eisai Co., Ltd. will launch ETAK( Antimicrobial Wet Wipes (classified as miscellaneous goods) containing long-acting antimicrobial agent ETAK on August 29, 2019 at pharmacies and drugstores countrywide.

From Eisai 29 Aug 2019

Drug combination could improve survival of lung transplant patients

Drug combination could improve survival of lung transplant patients

Lung transplantation can prolong the lives of patients with end-stage lung disease, but the median survival rate after lung transplant is less than six years, which has improved only slightly in recent decades.

28 Aug 2019

In India’s burgeoning pain market, U.S. drugmakers stand to gain

In India’s burgeoning pain market, U.S. drugmakers stand to gain

Pain, like death, is a universal phenomenon. The sour grimace on the woman's face, registering her bodily complaints to Dr. G.P. Dureja in his East Delhi office, would be recognized anywhere. Slouched shoulders, pinched forehead. She wore a willowy black kurta and cast a disapproving glance at the five pain physicians-in-training huddled behind Dureja, founder of Delhi Pain Management Centre and one of India's pioneering pain physicians.

28 Aug 2019

Medigrowth continues to achieve significant milestones in the Australian cannabis industry

Medigrowth continues to achieve significant milestones in the Australian cannabis industry

Today, Medigrowth Australia is pleased to provide an update on its activities. Victorian-based Medicinal Cannabis company Medigrowth continues to achieve significant milestones as it navigates a clear path to delivering on its commitment to become a valuable cannabis industry supply chain partner, large scale extraction company and provider of pure, safe and trusted pharmaceutical-grade medical cannabis for delivery to Australian patients.

28 Aug 2019

Study reveals link between popular pain medication and greater risk of hypoglycemia

Study reveals link between popular pain medication and greater risk of hypoglycemia

Since its approval in 1995, the opioid tramadol (marketed as ConZip and Ultram) has become a widely prescribed remedy for osteoarthritis and other painful indications, in part because it presents a lesser risk for some side effects and has a lower abuse potential when compared to other opioids.

28 Aug 2019

Pharma cash rolls into Congress to defend an embattled industry

Pharma cash rolls into Congress to defend an embattled industry

In the heat of the most ferocious battle over drug prices in years, pharmaceutical companies are showering U.S. senators with campaign cash as sweeping legislation heads toward the floor.

27 Aug 2019

Many drug manufacturers fail to complete the FDA approval process, research reveals

Many drug manufacturers fail to complete the FDA approval process, research reveals

The Food and Drug Administration's Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market.

27 Aug 2019

Out-of-pocket drug costs soar for Medicare patients with multiple sclerosis

Out-of-pocket drug costs soar for Medicare patients with multiple sclerosis

Over the course of a decade, out-of-pocket costs for multiple sclerosis drugs rose more than sevenfold for Medicare Part D beneficiaries, according to a JAMA Neurology study published today by researchers at the University of Pittsburgh.

26 Aug 2019

Skin patch delivers melanoma medication in one minute

Skin patch delivers melanoma medication in one minute

Researchers have developed a fast-acting skin patch that can deliver medication to treat melanoma in one minute.

26 Aug 2019

Head-to-head comparison of three breast cancer drugs reveals important differences

Head-to-head comparison of three breast cancer drugs reveals important differences

Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form--which tests positive for hormone receptors (HR+) and negative for the HER2 receptor--usually respond well to treatment.

23 Aug 2019

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.